B-cell involvement in chronic graft-versus-host disease [PDF]
Chronic graft-versus-host disease is a serious complication in long-term survivors of allogeneic hematopoietic stem cell transplantation, with several organ systems affected.
Rick Kapur +2 more
doaj +2 more sources
Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease [PDF]
Background Multipotent mesenchymal stromal cells suppress T-cell function in vitro, a property that has underpinned their use in treating clinical steroid-refractory graft-versus-host disease after allogeneic hematopoietic stem cell transplantation ...
Melinda E. Christensen +8 more
doaj +3 more sources
Human Graft Versus Host Disease [PDF]
Human graft versus host disease is composed of 2 distinct clinical entities, acute graft versus host disease and chronic graft versus host disease, which have different pathogenesis. Acute graft versus host disease is produced by the attack of donor immunocompetent T or null lymphocytes against recipient histocompatibility antigens.
Parkman, Robertson +2 more
openaire +3 more sources
Chronic graft-versus-host disease – the role of dermatological treatment [PDF]
Introduction . The number of allogeneic haematopoietic stem cell transplantations is increasing year by year. The most common long-term complication is chronic graft-versus-host disease, with skin involvement noted in over 90% of cases. Objective . To
Magdalena Żychowska +3 more
doaj +3 more sources
Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review [PDF]
Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplants (allo-HSCT) associated with significant morbidity and mortality. The earliest and most common manifestation is cutaneous graft-versus-host disease.
Cesar Daniel Villarreal Villarreal +3 more
doaj +4 more sources
Ocular Graft versus Host Disease [PDF]
Allogeneic hematopoietic stem cell transplantation is considered the standard of care for hematological and lymphoid malignancies. One of the complications associated to this therapy is an immune-mediated reaction known as graft versus host disease with ...
Paulo E.C. Dantas
doaj +2 more sources
Novel regulatory therapies for prevention of Graft-versus-host disease [PDF]
Graft-versus-host disease is one of the major transplant-related complications in allogeneic hematopoietic stem cell transplantation. Continued efforts have been made to prevent the occurrence of severe graft-versus-host disease by eliminating or ...
Leventhal Joseph +4 more
doaj +2 more sources
Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant [PDF]
Severe graft-versus-host disease is a major barrier for non-T-cell-depleted haploidentical stem cell transplantation. There is no consensus on the optimal graft-versus-host disease prophylaxis.
Annalisa Ruggeri +17 more
doaj +3 more sources
Skin-Limited Graft-versus-Host Disease after Pancreatic Transplantation [PDF]
Introduction. The phenomenon of graft-versus-host disease, a solid organ transplant recipient, is a rare development with a very poor prognosis. Case Presentation.
Muneeb Ilyas +5 more
doaj +2 more sources
acute exacerbation of graft-versus-host disease [PDF]
Photography at presentation. (A) Image of right eye (RE) showed prominent anterior chamber inflammation with posterior synechiae. Band keratopathy was due to ocular graft-versus-host disease and keratoconjunctivitis sicca.
Chen-Yu Lin (14613215)
core +1 more source

